nm. The formation of vesicles was confirmed by dynamic light scattering to ensure solution homogeneity.
Peptide preparation
In order to break up preformed aggregates in the initial peptide aliquot, both unlabeled and uniformly 15 N-labeled peptide was dissolved in 1% NH 4 OH and aliquoted to 0.1 mg/sample, and lyophilized. HiLyte Fluor 647-A 40 was similarly dissolved in 1% NH 4 OH and aliquoted to 0.01 mg/sample and lyophilized. All peptide was dried under vacuum for 48 h to remove excess moisture.
Circular dichroism studies
Circular dichroism (CD) measurements were carried out at a concentration of 20 M A 40 in the presence of 4 M LUV in buffer (20 mM PO 4 , 50 mM NaF, pH 7.4). Freshly lyophilized peptide was first dissolved in 5 L of 1% NH 4 OH prior to dilution into the buffer to prevent the formation of early aggregates. CD measurements were performed on a JASCO J-1500 CD Spectrometer using a 0.1 cm path length cell. The spectra were acquired at 10 °C at a scan rate of 100 nm/min and averaged over 10 scans. Measurements were taken immediately after mixing the sample (t = 0 h), after 4 h incubation at 4 °C, and after 24 h incubation at 4 °C.
Fluorescence anisotropy binding studies
To prepare the peptide for fluorescence experiments, HiLyte Fluor 647-A 40 was dissolved in 5 L 1% NH 4 OH and diluted into buffer (20 mM PO 4 , pH 7.4, 50 mM NaCl) to a final peptide concentration of 1 M. Fluorescence measurements were performed on a Jasco FP-6500 fluorimeter equipped with excitation and emission polarizing filters. Fluorescence polarization was used to measure the binding affinity of A 40 for 100 nm LUVs of the various lipids. 150 L of a 1 M solution of HiLyte Fluor 647-A 40 was titrated with LUVs from a 10 mg/mL stock solution. Lipid was titrated into peptide solution to a maximum concentration of 7 mM. The fluorescence anisotropy was monitored with an excitation wavelength of 647 nm and emission wavelength of 660 nm using a 10 nm bandwidth for both excitation and emission at each titration point. Anisotropy (<r>) was calculated using equation 1 where G is defined by equation 2. I is the intensity observed with excitation (first subscript) and emission (second subscript) polarizers set to either vertical or horizontal, providing four measurements which contribute to the anisotropy calculation. . For all experiments, spectral were processed using Topspin 2.1 (Bruker) while assignments and intensity fits were performed by SPARKY 3.113.
Transfer-NOESY (tr-NOESY)
Line broadening was first observed by 1D 1 H NMR upon the addition of 0.2 equiv (16 M) lipid, suggesting exchange between unbound and bound species; this peptide:lipid ratio was utilized throughout for lipid containing NMR samples and was observed to be stable over the course of the experiments. Therefore, transfer-NOESY (tr-NOESY) experiments were carried out on Bruker TCI 900 spectrometer, equipped with a cryo-probe to investigate the membrane bound state of unlabeled A 40 to the three LUVs. 1-3 Two-dimensional (2D) 1 H-1 H TOCSY and 1 H-1 H tr-NOESY spectra were acquired at 80 and 150 ms mixing times, respectively at 10 °C. Tr-NOESY spectra were acquired using 2 K data points in t 2 and 512 data points in t 1 and a spectral width of 12 ppm in both dimensions. H  chemical shifts were then calculated relative to the random coil shift values maintained by the Biological Magnetic Resource Bank (BMRB, University of Wisconsin).
Paramagnetic relaxation enhancement titration
A solution of MnCl 2 was titrated into a solution of uniformly 15 N-labeled A 40 in the presence of LUVs described above and monitored by SOFAST-HMQC on a Bruker 600 MHz spectrometer equipped with a cryoprobe at 10 °C. Spectra of each sample in the presence of 0 equiv (0 M), 0.5 equiv (40 M), and 1 equiv (80 M) MnCl 2 were obtained from 128 t 1 points and a 100 ms recycle delay. Relative intensities for all spectra were obtained by a comparison of spectra in the presence of spectra acquired in the presence of both 0.5 and 1.0 equiv MnCl 2 to spectra in the absence of the paramagnetic reagent. Peak assignments for the spectra were based on previously published spectra. 4 
